nach oben

Erschienen in:

06.01.2020

The Women’s Circle of Health Follow-Up Study: a population-based longitudinal study of Black breast cancer survivors in New Jersey

verfasst von: Elisa V. Bandera, Kitaw Demissie, Bo Qin, Adana A.M. Llanos, Yong Lin, Baichen Xu, Karen Pawlish, Jesse J. Plascak, Jennifer Tsui, Angela R. Omilian, William McCann, Song Yao, Christine B. Ambrosone, Chi-Chen Hong

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The Women’s Circle of Health Follow-Up Study is an ongoing longitudinal study of African American/Black breast cancer survivors in New Jersey, specifically designed to evaluate the impact of obesity and related comorbidities on breast cancer survival and health-related quality-of-life in this understudied population. Here, we describe our recruitment and data collection methods and compare characteristics of the overall cohort and the subcohort with follow-up data.

Methods

Newly diagnosed breast cancer cases have been recruited into the study since 2006. Pre-diagnosis data on relevant factors and a saliva sample are collected during an in-person interview within 12 months from diagnosis. In 2013, we began active follow up by recontacting participants annually, including two home visits at approximately 2 and 3 years post-diagnosis, during which blood samples are collected. Mortality outcomes (all-cause and breast cancer-specific mortality) are ascertained through linkage with New Jersey State Cancer Registry files. We expect to assemble a cohort of over 2000 Black breast cancer survivors with at least 800 of them having detailed post-diagnosis data.

Results

Distribution of sociodemographic characteristics, body mass index, comorbidities, clinicopathologic characteristics, and treatment modalities were very similar between those in the full cohort and the subset with follow-up data and blood samples. Obesity (> 50%), hypertension (> 58%), and diabetes (22%) were common in this population.

Conclusions and implications for cancer survivors

This ongoing longitudinal study represents a unique resource to better understand breast cancer outcomes, patient-reported symptoms, and health-related quality of life among Black breast cancer survivors.

Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, et al., 1975-2014, Annual Report to the Nation on the Status of Cancer, Featuring survival. J Natl Cancer Inst 2017;109(9).

DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Cancer statistics for African Americans, 2019. CA Cancer J Clin. 2019;69(3):211–33.PubMedCrossRef

Maskarinec G, Sen C, Koga K, Conroy SM. Ethnic differences in breast cancer survival: status and determinants. Women's Health (Lond Engl). 2011;7(6):677–87.CrossRef

Lee K, Kruper L, Dieli-Conwright CM, Mortimer JE. The impact of obesity on breast cancer diagnosis and treatment. Curr Oncol Rep. 2019;21(5):41.PubMedPubMedCentralCrossRef

Bandera EV, Maskarinec G, Romieu I, John EM. Racial and ethnic disparities in the impact of obesity on breast cancer risk and survival: a global perspective. Adv Nutr. 2015;6(6):803–19.PubMedPubMedCentralCrossRef

Ogden CL, Carroll MD, Flegal KM. Prevalence of obesity in the United States. JAMA. 2014;312(2):189–90.PubMedCrossRef

Ford ES, Maynard LM, Li C. Trends in mean waist circumference and abdominal obesity among US adults, 1999-2012. JAMA. 2014;312(11):1151–3.PubMedPubMedCentralCrossRef

Beydoun MA, Wang Y. Gender-ethnic disparity in BMI and waist circumference distribution shifts in US adults. Obesity. 2009;17(1):169–76.PubMedCrossRef

Parekh N, Chandran U, Bandera EV. Obesity in cancer survival. Annu Rev Nutr. 2012;32:311–42.PubMedCrossRef

10.

Chan DS, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25(10):1901–14.PubMedPubMedCentralCrossRef

11.

Dignam JJ, Wieand K, Johnson KA, Raich P, Anderson SJ, Somkin C, et al. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res Treat. 2006;97(3):245–54.PubMedCrossRef

12.

Paskett ED, Dean JA, Oliveri JM, Harrop JP. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol. 2012;30(30):3726–33.PubMedCrossRef

13.

Weaver KE, Foraker RE, Alfano CM, Rowland JH, Arora NK, Bellizzi KM, et al. Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv. 2013;7(2):253–61.PubMedPubMedCentralCrossRef

14.

Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. Jama. 2005;294(14):1765–72.PubMedCrossRef

15.

Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, et al. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer. 2009;124(5):1213–9.PubMedCrossRef

16.

Polednak AP. Racial differences in mortality from obesity-related chronic diseases in US women diagnosed with breast cancer. Ethn Dis. 2004;14(4):463–8.PubMed

17.

Hong CC, Ambrosone CB, Goodwin PJ. Comorbidities and their management: potential impact on breast cancer outcomes. Adv Exp Med Biol. 2015;862:155–75.PubMedCrossRef

18.

Van Wyhe RD, Rahal OM, Woodward WA, 2017. Effect of statins on breast cancer recurrence and mortality: a review. Breast Cancer (Dove Med Press), 9:559–65.

19.

Peeters PJ, Bazelier MT, Vestergaard P, Leufkens HG, Schmidt MK, de Vries F, et al. Use of metformin and survival of diabetic women with breast cancer. Curr Drug Saf. 2013;8(5):357–63.PubMedPubMedCentralCrossRef

20.

Childers WK, Hollenbeak CS, Cheriyath P. Beta-blockers reduce breast cancer recurrence and breast cancer death: a meta-analysis. Clin Breast Cancer. 2015;15(6):426–31.PubMedCrossRef

21.

Ambrosone CB, Ciupak GL, Bandera EV, Jandorf L, Bovbjerg DH, Zirpoli G, et al. Conducting molecular epidemiological research in the age of HIPAA: a multi-institutional case-control study of breast cancer in African-American and European-American women. J Oncol. 2009;2009:871250.PubMedPubMedCentralCrossRef

22.

Yao S, Zirpoli G, Bovbjerg DH, Jandorf L, Hong CC, Zhao H, et al. Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res. 2012;14(2):R58.PubMedPubMedCentralCrossRef

23.

Bandera EV, Chandran U, Zirpoli G, Ciupak G, Bovbjerg DH, Jandorf L, et al. Body size in early life and breast cancer risk in African American and European American women. Cancer Causes Control. 2013;24(12):2231–43.PubMedPubMedCentralCrossRef

24.

Bandera EV, Chandran U, Zirpoli G, Gong Z, McCann SE, Hong CC, et al. Body fatness and breast cancer risk in women of African ancestry. BMC Cancer. 2013;13:475.PubMedPubMedCentralCrossRef

25.

Chandran U, Zirpoli G, Ciupak G, McCann SE, Gong Z, Pawlish K, et al. Racial disparities in red meat and poultry intake and breast cancer risk. Cancer Causes Control. 2013;24(12):2217–29.PubMedPubMedCentralCrossRef

26.

Chandran U, Zirpoli G, Ciupak G, McCann SE, Gong Z, Pawlish K, et al. Does alcohol increase breast cancer risk in African-American women? Findings from a case-control study. Br J Cancer. 2013;109(7):1945–53.PubMedPubMedCentralCrossRef

27.

Gong Z, Ambrosone CB, McCann SE, Zirpoli G, Chandran U, Hong CC, et al. Associations of dietary folate, vitamins B6 and B12 and methionine intake with risk of breast cancer among African American and European American women. Int J Cancer. 2014;134(6):1422–35.PubMedCrossRef

28.

Gong Z, Quan L, Yao S, Zirpoli G, Bandera EV, Roberts M, et al. Innate immunity pathways and breast cancer risk in African American and European-American women in the Women’s Circle of Health Study (WCHS). PLoS One. 2013;8(8):e72619.PubMedPubMedCentralCrossRef

29.

Quan L, Gong Z, Yao S, Bandera EV, Zirpoli G, Hwang H, et al. Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry. Int J Cancer. 2014;134(6):1408–21.PubMedCrossRef

30.

Yao S, Graham K, Shen J, Campbell LE, Singh P, Zirpoli G, et al. Genetic variants in microRNAs and breast cancer risk in African American and European American women. Breast Cancer Res Treat. 2013;141(3):447–59.PubMedPubMedCentralCrossRef

31.

Ambrosone CB, Zirpoli G, Ruszczyk M, Shankar J, Hong CC, McIlwain D, et al. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women’s Circle of Health Study. Cancer Causes Control. 2014;25(2):259–65.PubMedCrossRef

32.

Ambrosone CB, Zirpoli GR, Bovbjerg DH, Shankar J, Hong CC, McCann SE, et al. Associations between estrogen receptor-negative breast cancer and timing of reproductive events differ between African American and European American women. Cancer Epidemiol Biomark Prev. 2014;23(6):1115–20.CrossRef

33.

Chandran U, McCann SE, Zirpoli G, Gong Z, Lin Y, Hong CC, et al. Intake of energy-dense foods, fast foods, sugary drinks, and breast cancer risk in African American and European American women. Nutr Cancer. 2014;66(7):1187–99.PubMedPubMedCentralCrossRef

34.

Gong Z, Yao S, Zirpoli G, David Cheng TY, Roberts M, Khoury T, et al. Genetic variants in one-carbon metabolism genes and breast cancer risk in European American and African American women. Int J Cancer. 2015;137(3):666–77.PubMedPubMedCentralCrossRef

35.

Llanos AA, Chandwani S, Bandera EV, Hirshfield KM, Lin Y, Ambrosone CB, et al. Associations between sociodemographic and clinicopathological factors and breast cancer subtypes in a population-based study. Cancer Causes Control. 2015;26(12):1737–50.PubMedPubMedCentralCrossRef

36.

Llanos AAM, Rabkin A, Bandera EV, Zirpoli G, Gonzalez BD, Xing CY, et al. Hair product use and breast cancer risk among African American and white women. Carcinogenesis. 2017;38(9):883–92.PubMedPubMedCentralCrossRef

37.

George PA, 2012. Racial Disparities in Early Stage Breast Cancer Treatment (Doctoral Dissertation; Dissertation Director: Kitaw Demissie, MD, PhD). Rutgers University, New Brunswick, NJ. Record ID: oai:example.org:Rutgers-lib: 38770

38.

Chandwani S., 2012, Factors Contributing to Disparities in Early Breast Cancer Treatment (Doctoral Dissertation; Dissertation Director: Kitaw Demissie, MD, PhD). Rutgers University, New Brunswick, NJ. Record ID:oai:example.org:Rutgers-lib:38723

39.

Chandwani S, George PA, Azu M, Bandera EV, Ambrosone CB, Rhoads GG, et al. Role of preoperative magnetic resonance imaging in the surgical management of early-stage breast cancer. Ann Surg Oncol. 2014;21(11):3473–80.PubMedPubMedCentralCrossRef

40.

George P, Chandwani S, Gabel M, Ambrosone CB, Rhoads G, Bandera EV, et al. Diagnosis and surgical delays in african american and white women with early-stage breast cancer. J Women's Health (Larchmt). 2015;24(3):209–17.CrossRef

41.

Goyal S, Chandwani S, Haffty BG, Demissie K. Effect of travel distance and time to radiotherapy on likelihood of receiving mastectomy. Ann Surg Oncol. 2015;22(4):1095–101.PubMedCrossRef

42.

Krishnan S, Rosenberg L, Palmer JR. Physical activity and television watching in relation to risk of type 2 diabetes: the black women’s health study. Am J Epidemiol. 2009;169(4):428–34.PubMedCrossRef

43.

Carter-Nolan PL, Adams-Campbell LL, Makambi K, Lewis S, Palmer JR, Rosenberg L. Validation of physical activity instruments: black women’s health study. Ethn Dis. 2006;16(4):943–7.PubMed

44.

Genkinger JM, Makambi KH, Palmer JR, Rosenberg L, Adams-Campbell LL. Consumption of dairy and meat in relation to breast cancer risk in the black women’s health study. Cancer Causes Control. 2013;24(4):675–84.PubMedPubMedCentralCrossRef

45.

Block G, Am H, Cm D, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol. 1986;124:453–69.PubMedCrossRef

46.

Krieger N, Smith K, Naishadham D, Hartman C, Barbeau EM. Experiences of discrimination: validity and reliability of a self-report measure for population health research on racism and health. Soc Sci Med. 2005;61(7):1576–96.PubMedCrossRef

47.

Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.CrossRefPubMed

48.

Hays RD, Sherbourne CD, Mazel RM. The RAND 36-item health survey 1.0. Health Econ 1993;2(3):217–227.CrossRefPubMed

49.

Qin B, Llanos AAM, Lin Y, Szamreta EA, Plascak JJ, Oh H, et al. Validity of self-reported weight, height, and body mass index among African American breast cancer survivors. J Cancer Surviv. 2018;12(4):460–8.PubMedPubMedCentralCrossRef

50.

Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111(5):697–716.PubMedCrossRef

51.

Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves JW, Hill MN, et al. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens. 2005;7(2):102–9.CrossRef

52.

Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, et al. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol. 1997;15(3):974–86.PubMedCrossRef

53.

Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected] The Upper Extremity Collaborative Group (UECG). Am J Ind Med 1996;29(6):602–608.

54.

Marx RG, Bombardier C, Hogg-Johnson S, Wright JG. Clinimetric and psychometric strategies for development of a health measurement scale. J Clin Epidemiol. 1999;52(2):105–11.PubMedCrossRef

55.

Bot SD, Terwee CB, van der Windt DA, Bouter LM, Dekker J, de Vet HC. Clinimetric evaluation of shoulder disability questionnaires: a systematic review of the literature. Ann Rheum Dis. 2004;63(4):335–41.PubMedPubMedCentralCrossRef

56.

Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res. 2006;12(9):2759–66.PubMedCrossRef

57.

Schubert C, Hong S, Natarajan L, Mills PJ, Dimsdale JE. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun. 2007;21:413–27.PubMedCrossRef

58.

Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett. 2004;361(1–3):184–7.PubMedCrossRef

59.

Miaskowski C, Cooper BA, Dhruva A, Dunn LB, Langford DJ, Cataldo JK, et al. Evidence of associations between cytokine genes and subjective reports of sleep disturbance in oncology patients and their family caregivers. PLoS One. 2012;7(7):e40560.PubMedPubMedCentralCrossRef

60.

Illi J, Miaskowski C, Cooper B, Levine JD, Dunn L, West C, et al. Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression. Cytokine. 2012;58(3):437–47.PubMedPubMedCentralCrossRef

61.

Irwin M. Effects of sleep and sleep loss on immunity and cytokines. Brain Behav Immun. 2002;16(5):503–12.PubMedCrossRef

62.

Andersen BL, Farrar WB, Golden-Kreutz DM, Glaser R, Emery CF, Crespin TR, et al. Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J Clin Oncol. 2004;22(17):3570–80.PubMedCrossRef

63.

Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med. 2003;65(4):571–81.PubMedCrossRef

64.

Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the functional assessment of chronic illness therapy fatigue scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol. 2005;32(5):811–9.PubMed

65.

Sorenson M, Janusek L, Mathews H. Psychological stress and cytokine production in multiple sclerosis: correlation with disease symptomatology. Biol Research Nurs. 2013;15(2):226–33.CrossRef

66.

Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–96.PubMedCrossRef

67.

Matthews AK, Tejeda S, Johnson TP, Berbaum ML, Manfredi C. Correlates of quality of life among African American and white cancer survivors. Cancer Nurs. 2012;35(5):355–64.PubMedPubMedCentralCrossRef

68.

Gregg G. I'm a Jesus girl: coping stories of Black American women diagnosed with breast cancer. J Relig Health. 2011;50(4):1040–53.PubMedCrossRef

69.

Bellizzi KM, Smith AW, Reeve BB, Alfano CM, Bernstein L, Meeske K, et al. Posttraumatic growth and health-related quality of life in a racially diverse cohort of breast cancer survivors. J Health Psychol. 2010;15(4):615–26.PubMedCrossRef

70.

Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy--Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med. 2002;24(1):49–58.PubMedCrossRef

71.

Gullate M. The influence of spirituality and religiosity on breast cancer screening delay in African American women: application of the Theory of Reasoned Action and Planned Behavior (TRA/TPB). ABNF J. 2006;17(2):89–94.PubMed

72.

Gullatte MM, Phillips JM, Gibson LM. Factors associated with delays in screening of self-detected breast changes in African-American women. JNBNA. 2006;17(1):45–50.PubMed

73.

Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. Int J behav Med. 2008;15(3):194–200.PubMedCrossRef

74.

Ambrosone CB, Nesline MK, Davis W. Establishing a cancer center data bank and biorepository for multidisciplinary research. Cancer Epidemiol, Biomarkers Prev. 2006;15(9):1575–7.CrossRef

75.

Carroll J, Protani M, Walpole E, Martin JH. Effect of obesity on toxicity in women treated with adjuvant chemotherapy for early-stage breast cancer: a systematic review. Breast Cancer Res Treat. 2012;136(2):323–30.PubMedCrossRef

76.

Kravitz RL, Greenfield S, Rogers W, Manning WG Jr, Zubkoff M, Nelson EC, et al. Differences in the mix of patients among medical specialties and systems of care. Results from the medical outcomes study. JAMA. 1992;267(12):1617–23.PubMedCrossRef

77.

the American Diabetes Association, 2015, Standards of medical care in diabetes-2015 abridged for primary care providers. Clinical diabetes : a publication of.;33(2):97–111.

78.

James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama. 2014;311(5):507–20.PubMedCrossRef

79.

NHLBI. Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). National Institutes of Health; 2002.

80.

National KF. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.

81.

Kwan ML, Ambrosone CB, Lee MM, Barlow J, Krathwohl SE, Ergas IJ, et al. The pathways study: a prospective study of breast cancer survivorship within Kaiser Permanente northern California. Cancer Causes Control. 2008;19(10):1065–76.PubMedPubMedCentralCrossRef

82.

John EM, Sangaramoorthy M, Koo J, Whittemore AS, West DW. Enrollment and biospecimen collection in a multiethnic family cohort: the northern California site of the breast cancer family registry. Cancer Causes Control. 2019;30(4):395–408.PubMedPubMedCentralCrossRef

83.

Caan B, Sternfeld B, Gunderson E, Coates A, Quesenberry C, Slattery ML. Life after cancer epidemiology (LACE) study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control. 2005;16(5):545–56.PubMedCrossRef

Titel: The Women’s Circle of Health Follow-Up Study: a population-based longitudinal study of Black breast cancer survivors in New Jersey
verfasst von: Elisa V. Bandera
Kitaw Demissie
Bo Qin
Adana A.M. Llanos
Yong Lin
Baichen Xu
Karen Pawlish
Jesse J. Plascak
Jennifer Tsui
Angela R. Omilian
William McCann
Song Yao
Christine B. Ambrosone
Chi-Chen Hong
Publikationsdatum: 06.01.2020
Verlag: Springer US
Erschienen in: Journal of Cancer Survivorship / Ausgabe 3/2020
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-019-00849-8

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

The Women’s Circle of Health Follow-Up Study: a population-based longitudinal study of Black breast cancer survivors in New Jersey

Abstract

Purpose

Methods

Results

Conclusions and implications for cancer survivors

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions and implications for cancer survivors

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Clinical trajectories, healthcare resource use, and costs of long-term hematopoietic stem cell transplantation survivors: a latent class analysis

The impact of arm lymphedema on healthcare utilization during long-term breast cancer survivorship: a population-based cohort study

Developing the structure of Japan’s cancer survivorship guidelines using an expert panel and modified Delphi method

Risk factors for cancer-related distress in colorectal cancer survivors: one year post surgery

Distinct trajectories of moderate to vigorous physical activity and sedentary behavior following a breast cancer diagnosis: the Pathways Study

Comparison of health behaviours between cancer survivors and the general population: a cross-sectional analysis of the Lifelines cohort

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie